ACTEMRA 400mg/20mL (Tocilizumab) is an intravenous monoclonal antibody that blocks IL-6 receptors to treat inflammatory conditions such as rheumatoid arthritis, giant cell arteritis, juvenile idiopathic arthritis, cytokine release syndrome, and severe COVID-19 pneumonia.
| Brand | ACTEMRA® |
|---|---|
| Manufacturer | Genentech |
| Active Substances | TOCILIZUMAB |
| Strength | 400mg/20ml |
| Pack Size | 1 x 20ml Vial |
